Steve Scala

facebook_page
twitter_page

Last quote by Steve Scala

Opdivo sales could be at risk given possible availability of Merck's Keytruda/chemo combo in the second quarter, and there might be more risk in earnings per share given that lung market dynamics are changing quickly.
Jan 20 2017
Steve Scala has been quoted in 1 different article. Most recently, Steve Scala has been quoted saying, “Opdivo sales could be at risk given possible availability of Merck's Keytruda/chemo combo in the second quarter, and there might be more risk in earnings per share given that lung market dynamics are changing quickly.” in an article called Bristol-Myers shares fall on lung cancer timeline setback. This is only one of 1 quote from Steve Scala. To see more examples Steve Scala’s views and opinions, check out the section below. You can filter Steve Scala's quotes by date and by topic to see, for example, what Steve Scala said about Merck recently and in the past.
Automatically powered byStoryzy
<
facebook_page
twitter_page